• 

GEN Live: How Oligonucleotide Therapeutics May Change the Course of Rare Diseases

September 20, 2023

Andrew Andrew Serrano2023-10-03T22:58:26-04:00

Read More

Stanley T. Crooke, M.D., Ph.D., Founder, Chairman and CEO of n-Lorem, Presented with the 2022 Steven C. Beering Award

n-Lorem founder, [...]

Andrew Andrew Serrano2023-09-20T16:53:06-04:00

Read More

n-Lorem Foundation Founder and CEO, Stanley Crooke, M.D., Ph.D., Awarded the Steven C. Beering Award

Prestigious award recognizes Dr. [...]

Andrew Andrew Serrano2023-11-22T16:23:47-04:00

Read More

• 

Liver: Diseases

There are [...]

Andrew Andrew Serrano2024-02-05T22:01:47-04:00

Read More

• 

Liver: The Master Chemist

The liver [...]

Andrew Andrew Serrano2024-02-05T21:59:50-04:00

Read More

n-Lorem Has Industrialized the Treatment of Nano-rare Patients and Formed Key Committees

Committees structured to ensure [...]

Andrew Andrew Serrano2023-10-11T00:57:27-04:00

Read More

• 

Liver: Metabolic Magic

You can [...]

Andrew Andrew Serrano2024-02-05T21:57:21-04:00

Read More

n-Lorem Publishes Paper Defining Needed Health Care Reforms to Provide an Integrated Holistic Approach for Nano-rare Patients

Publication characterizes [...]

Andrew Andrew Serrano2023-10-11T00:56:47-04:00

Read More

A way forward for diagnosis of patients with extremely rare genetic mutations

Crooke, S.T., Kim-McManus, O.S., Dalby, K.

Andrew Andrew Serrano2023-07-18T16:26:09-04:00

Read More

• 

Bottling Hope

with Wayne Woodard

Andrew Andrew Serrano2023-10-17T17:14:27-04:00

Read More